In vivo monitoring of liver damage using caspase-3 probe

Theranostics

Volumn 2, Issue 2, 2012, Pages 207-214

  Ozaki, Michitaka ^a   Haga, Sanae ^a,b   Ozawa, Takeaki ^c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bioluminescence; Imaging; Luciferase.; Non invasive monitoring; Optical probe

Indexed keywords

CASPASE 3; FAS LIGAND; LUCIFERASE; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; HYPOXIA; IN VIVO STUDY; LIVER INJURY; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; OPTICAL INSTRUMENTATION; REOXYGENATION; REPERFUSION INJURY;

EID: 84864544057     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3806     Document Type: Article

References (15)

1. Dooley CT, Dore TM, Hanson GT et al. Imaging dynamic redox changes in mammalian cells with green fluorescent protein in-dicators. J Biol Chem. 2004; 279: 22284-93.
2. Kanno A, Yamanaka Y, Hirano H et al. Cyclic luciferase for real-time sensing of caspase-3 activities in living mammals. Angew Chem Int Ed. 2007; 46: 7595-9.
3. Zhu L, Xie J, Swierczewska M et al. Real-time video imaging of protease expression in vivo. Theranostics. 2011; 1: 18-27.
4. Lexman B, Hall DE, Bhojani MS et al. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A. 2002; 99: 16551-5.
5. Ray P, De A, Patel M, Gambhir SS. Monitoring caspase-3 acti-vation with a multimodality imaging sensor in living subjects. Clin Cancer Res. 2008; 14: 5801-9.
6. Yhee JY, Kim SA, Koo H et al. Optical imaging of cancer-related proteases using near-infrared fluorescence matrix metallopro-teinase-sensitive and cathepsin B-sensitive probes. Theranostics. 2012; 2: 179-89.
7. Kim GB, Kim Y.-P. Analysis of protease activity using quantum dots. Theranostics. 2012; 2: 127-38.
8. Ozaki M, Deshpande SS, Angkeow P et al. Inhibition of the Rac1 GTPase protects against nonlethal ische-mia/reperfusion-induced necrosis and apoptosis in vivo. Faseb J. 2000; 14: 418-29.
9. Lucchesi, BR. Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke. 1993; 24: I41-7.
10. Haga S, Remington S, Morita N et al. Hepatic ischemia induced immediate oxidative stress after reperfusion and determined the severity of the reperfusion-induced damage. Antioxid Re-dox Signal. 2009; 11: 2563-72.
11. Pinkoski MJ, Brunner T, Green D.R et al. Fas and Fas ligand in gut and liver. Am J Physiol Gastrointest Liver Physiol. 2000; 278: G354-66.
12. Galle PR, Hofmann WJ, Walczak H et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med. 1995; 182: 1223-30.
13. Kanzler S, Galle PR. Apoptosis and the liver. Semin Cancer Biol. 2000; 10: 173-84.
14. Faubion WA, Guicciardi ME, Miyoshi H et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest. 1999; 103: 137-45.
15. Shc plays a pivotal role in impaired liver regeneration in aged mice by a redox-dependent mechanism. Lab Invest. 2010; 90: 1718-26.